⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Fertin Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Fertin Pharma
↗Vejle, Denmark
Fertin Pharma is a leading Contract Development and Manufacturing Organization (CDMO) specializing in innovative oral and intra-oral delivery systems. The company leverages over 100 years of confectionery heritage combined with advanced pharmaceutical manufacturing capabilities to develop products such as medicated chewing gum, lozenges, and fast-dissolving tablets (ZapLiq®).
Headquartered in Denmark, Fertin Pharma supports global brands in the pharmaceutical and nutraceutical sectors, focusing on areas like Nicotine Replacement Therapy (NRT), pain management, oral care, and gastrointestinal health. Since its 2021 acquisition by Philip Morris International (PMI), the company has served as a key vehicle for PMI's expansion into smoke-free, wellness, and self-care product categories.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1915
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Oral delivery systems, Medicated chewing gum, Lozenges, Fast-dissolving tablets
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Philip Morris International
Acquired By:Philip Morris International (2021-09-01)
Key Partnerships:Global pharmaceutical and nutraceutical brands (partnerships are typically confidential CDMO agreements)
COMPETITION
Position:Leader
Competitors:Catalent, Lonza, Patheon (Thermo Fisher Scientific), Aenova Group
LEADERSHIP
Key Executives:
Jacek Olczak - CEO (Philip Morris International)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Fertin Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.